A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus
מצבים רפואיים
MASH - Metabolic Dysfunction-Associated Steatohepatitis · T2DM (Type 2 Diabetes Mellitus)
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Ditan Hospital of integrated traditional Chinese and Western Medicine Center, Beijing, Beijing Municipality, China
Southwest Hospital of Third Military Medical University, Chongqing, Chongqing Municipality, China
The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Southern Hospital, Guangzhou, Guangdong, China
Wuhan Union Hospital of Huazhong University of Science and Technology, Wuhan, Hebei, China
Taihe Hospital, Shiyan, Hubei, China
Xiangya hospital of Central South University, Changsha, Hunan, China
The First Affiliated Hospital of Jilin University, Changchun, Jilin, China
Renji hospital of Shanghai Jiao Tong University School of Medical, Shanghai, Shanghai Municipality, China
Ruijin Hospital of Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai Municipality, China
Shanghai Public Health Clinical Center, Shanghai, Shanghai Municipality, China
Shanghai Punan Hospital of Pudong New District (Punan Branch of Renji Hospital, Shanghai Jiaotong University School of Medicine), Shanghai, Shanghai Municipality, China
The First Affiliated Hospital of Xi'an Jiao Tong University, Xi’an, Shanxi, China
Tianjin Second People's Hospital, Tianjin, Tianjin Municipality, China
The First Teaching Hospital of Xinjiang Medical University, Ürümqi, Xinjiang, China
The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China
מובילי המחקר
Hai Li, professor
Principal Investigator
Shanghai Punan Hospital of Pudong New District (Punan Branch of Renji Hospital, Shanghai Jiaotong University School of Medicine)